These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32004078)

  • 1. External validation and comparison of the CardShock and IABP-SHOCK II risk scores in real-world cardiogenic shock patients.
    Rivas-Lasarte M; Sans-Roselló J; Collado-Lledó E; González-Fernández V; Noriega FJ; Hernández-Pérez FJ; Fernández-Martínez J; Ariza A; Lidón RM; Viana-Tejedor A; Segovia-Cubero J; Harjola VP; Lassus J; Thiele H; Sionis A
    Eur Heart J Acute Cardiovasc Care; 2020 Jan; ():. PubMed ID: 32004078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Prognostic Accuracy of Risk Prediction Models for Cardiogenic Shock.
    Miller RJH; Southern D; Wilton SB; James MT; Har B; Schnell G; van Diepen S; Grant ADM
    J Intensive Care Med; 2020 Dec; 35(12):1513-1519. PubMed ID: 31610748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Prognostic Impact of IABP-SHOCK II Scores According to Treatment Strategy in Cardiogenic Shock Complicating Acute Coronary Syndrome: From the RESCUE Registry.
    Kim BS; Jang WJ; Choi KH; Kim SH; Yu CW; Jeong JO; Lee HJ; Gwon HC; Kim HJ; Yang JH
    Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38276062
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation.
    Schwarz B; Abdel-Wahab M; Robinson DR; Richardt G
    Med Klin Intensivmed Notfmed; 2016 Nov; 111(8):715-722. PubMed ID: 26596273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early risk stratification in patients with cardiogenic shock irrespective of the underlying cause - the Cardiogenic Shock Score.
    Beer BN; Jentzer JC; Weimann J; Dabboura S; Yan I; Sundermeyer J; Kirchhof P; Blankenberg S; Schrage B; Westermann D
    Eur J Heart Fail; 2022 Apr; 24(4):657-667. PubMed ID: 35119176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction.
    Pöss J; Köster J; Fuernau G; Eitel I; de Waha S; Ouarrak T; Lassus J; Harjola VP; Zeymer U; Thiele H; Desch S
    J Am Coll Cardiol; 2017 Apr; 69(15):1913-1920. PubMed ID: 28408020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality risk prediction in elderly patients with cardiogenic shock: results from the CardShock study.
    Hongisto M; Lassus J; Tarvasmäki T; Sionis A; Sans-Rosello J; Tolppanen H; Kataja A; Jäntti T; Sabell T; Lindholm MG; Banaszewski M; Silva Cardoso J; Parissis J; Di Somma S; Carubelli V; Jurkko R; Masip J; Harjola VP;
    ESC Heart Fail; 2021 Apr; 8(2):1398-1407. PubMed ID: 33522124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical picture, management and risk stratification in patients with cardiogenic shock: does gender matter?
    Collado-Lledó E; Llaó I; Rivas-Lasarte M; González-Fernández V; Noriega FJ; Hernández-Perez FJ; Alegre O; Sionis A; Lidón RM; Viana-Tejedor A; Segovia-Cubero J; Ariza-Solé A
    BMC Cardiovasc Disord; 2020 Apr; 20(1):189. PubMed ID: 32664921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.
    Unverzagt S; Buerke M; de Waha A; Haerting J; Pietzner D; Seyfarth M; Thiele H; Werdan K; Zeymer U; Prondzinsky R
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD007398. PubMed ID: 25812932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Mortality Risk Models in Patients with Postcardiac Arrest Cardiogenic Shock and Percutaneous Mechanical Circulatory Support.
    Chatzis G; Markus B; Syntila S; Waechter C; Luesebrink U; Ahrens H; Divchev D; Schieffer B; Karatolios K
    J Interv Cardiol; 2021; 2021():8843935. PubMed ID: 33536855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COMPARISON OF THE PREDICTIVE PERFORMANCE OF CARDIOGENIC SHOCK SCORES IN A REAL-WORLD LATIN AMERICA COUNTRY.
    Ortega-Hernández J; González-Pacheco H; Nieto RG; Araiza-Garaygordobil D; Lara-Martínez DS; De La Cruz JLB; Mendoza-García S; Altamirano-Castillo A; Orozco ÁM; Herrera LAB; Hernández-Montfort J; Aguilar-Montaño KM; Uriona LAS; López JÁFM; Loría CAL; Arias-Mendoza A
    Shock; 2023 Apr; 59(4):576-582. PubMed ID: 36821419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of intra-aortic balloon pump counterpulsation in the treatment of acute myocardial infarction complicated by cardiogenic shock: Evidence from the Portuguese nationwide registry.
    Timóteo AT; Nogueira MA; Rosa SA; Belo A; Ferreira RC;
    Eur Heart J Acute Cardiovasc Care; 2016 Nov; 5(7):23-31. PubMed ID: 26373810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reperfusion therapy and mechanical circulatory support in patients in cardiogenic shock].
    Scholz KH
    Herz; 1999 Oct; 24(6):448-64. PubMed ID: 10546149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-aortic balloon pump may grant no benefit to improve the mortality of patients with acute myocardial infarction in short and long term: an updated meta-analysis.
    Su D; Yan B; Guo L; Peng L; Wang X; Zeng L; Ong H; Wang G
    Medicine (Baltimore); 2015 May; 94(19):e876. PubMed ID: 25984680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients.
    Schäfer A; Werner N; Burkhoff D; Sieweke JT; Zietzer A; Masyuk M; Junker Udesen NL; Westenfeld R; Møller JE
    Front Cardiovasc Med; 2020; 7():74. PubMed ID: 32478095
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
    Sanborn TA; Sleeper LA; Bates ER; Jacobs AK; Boland J; French JK; Dens J; Dzavik V; Palmeri ST; Webb JG; Goldberger M; Hochman JS
    J Am Coll Cardiol; 2000 Sep; 36(3 Suppl A):1123-9. PubMed ID: 10985715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.
    Unverzagt S; Machemer MT; Solms A; Thiele H; Burkhoff D; Seyfarth M; de Waha A; Ohman EM; Buerke M; Haerting J; Werdan K; Prondzinsky R
    Cochrane Database Syst Rev; 2011 Jul; (7):CD007398. PubMed ID: 21735410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction.
    Abdel-Wahab M; Saad M; Kynast J; Geist V; Sherif MA; Richardt G; Toelg R
    Am J Cardiol; 2010 Apr; 105(7):967-71. PubMed ID: 20346314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intra-aortic balloon pump on in-hospital outcomes and 1-year mortality in patients with acute myocardial infarction complicated by cardiogenic shock.
    Fang D; Yu D; Xu J; Ma W; Zhong Y; Chen H
    BMC Cardiovasc Disord; 2023 Aug; 23(1):425. PubMed ID: 37644466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome.
    Prondzinsky R; Lemm H; Swyter M; Wegener N; Unverzagt S; Carter JM; Russ M; Schlitt A; Buerke U; Christoph A; Schmidt H; Winkler M; Thiery J; Werdan K; Buerke M
    Crit Care Med; 2010 Jan; 38(1):152-60. PubMed ID: 19770739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.